Literature DB >> 19345322

Glioma stem cells: not all created equal.

Howard A Fine1.   

Abstract

A growing body of evidence suggests that only a small subpopulation of malignant glioma cells have true tumorigenic potential. A study by Peñuelas et al. in this issue of Cancer Cell demonstrates that TGF-beta can stimulate self-renewal and inhibit differentiation in a proportion of these glioma-initiating cells.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19345322      PMCID： PMC6852885          DOI： 10.1016/j.ccr.2009.03.010

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  9 in total

1.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

2.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

Authors:  S G M Piccirillo; B A Reynolds; N Zanetti; G Lamorte; E Binda; G Broggi; H Brem; A Olivi; F Dimeco; A L Vescovi
Journal:  Nature       Date:  2006-12-07       Impact factor: 49.962

Review 3.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

4.  Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

Authors:  Jeongwu Lee; Myung Jin Son; Kevin Woolard; Nicholas M Donin; Aiguo Li; Chui H Cheng; Svetlana Kotliarova; Yuri Kotliarov; Jennifer Walling; Susie Ahn; Misuk Kim; Mariam Totonchy; Thomas Cusack; Chibawanye Ene; Hilary Ma; Qin Su; Jean Claude Zenklusen; Wei Zhang; Dragan Maric; Howard A Fine
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

5.  TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.

Authors:  Silvia Peñuelas; Judit Anido; Rosa M Prieto-Sánchez; Gerard Folch; Ignasi Barba; Isabel Cuartas; David García-Dorado; M Antonia Poca; Juan Sahuquillo; Jose Baselga; Joan Seoane
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

6.  Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion.

Authors:  Sven Falk; Heiko Wurdak; Lars M Ittner; Fabian Ille; Grzegorz Sumara; Marie-Theres Schmid; Kalina Draganova; Karl S Lang; Christian Paratore; Per Leveen; Ueli Suter; Stefan Karlsson; Walter Born; Romeo Ricci; Magdalena Götz; Lukas Sommer
Journal:  Cell Stem Cell       Date:  2008-05-08       Impact factor: 24.633

7.  Cancerous stem cells can arise from pediatric brain tumors.

Authors:  Houman D Hemmati; Ichiro Nakano; Jorge A Lazareff; Michael Masterman-Smith; Daniel H Geschwind; Marianne Bronner-Fraser; Harley I Kornblum
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205

8.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

9.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962
  9 in total
  12 in total

1.  Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients.

Authors:  Kelli B Pointer; Paul A Clark; Kevin W Eliceiri; M Shahriar Salamat; Gail A Robertson; John S Kuo
Journal:  Clin Cancer Res       Date:  2016-09-15       Impact factor: 12.531

Review 2.  Glioblastoma cancer stem cells: Biomarker and therapeutic advances.

Authors:  Kelli B Pointer; Paul A Clark; Michael Zorniak; Bahauddeen M Alrfaei; John S Kuo
Journal:  Neurochem Int       Date:  2014-03-19       Impact factor: 3.921

Review 3.  The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates.

Authors:  Suojun Zhang; Xiao Luo; Feng Wan; Ting Lei
Journal:  Neurochem Res       Date:  2012-09-19       Impact factor: 3.996

4.  Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges.

Authors:  Jin-Ku Lee; DO-Hyun Nam; Jeongwu Lee
Journal:  Oncol Lett       Date:  2016-01-07       Impact factor: 2.967

5.  Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma.

Authors:  Stephany Y Tzeng; Hugo Guerrero-Cázares; Elliott E Martinez; Joel C Sunshine; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  Biomaterials       Date:  2011-05-04       Impact factor: 12.479

6.  Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.

Authors:  Liliana Soroceanu; Lisa Matlaf; Sabeena Khan; Armin Akhavan; Eric Singer; Vladimir Bezrookove; Stacy Decker; Saleena Ghanny; Piotr Hadaczek; Henrik Bengtsson; John Ohlfest; Maria-Gloria Luciani-Torres; Lualhati Harkins; Arie Perry; Hong Guo; Patricia Soteropoulos; Charles S Cobbs
Journal:  Cancer Res       Date:  2015-08-01       Impact factor: 12.701

7.  Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.

Authors:  Michael Zorniak; Paul A Clark; Heather E Leeper; Matthew D Tipping; David M Francis; Kevin R Kozak; M Shahriar Salamat; John S Kuo
Journal:  Clin Cancer Res       Date:  2012-05-15       Impact factor: 12.531

8.  Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative Stress.

Authors:  Tom M Thomas; Ken Miyaguchi; Lincoln A Edwards; Hongqiang Wang; Hassen Wollebo; Li Aiguo; Ramachandran Murali; Yizhou Wang; Daniel Braas; Justin S Michael; Allen M Andres; Miqin Zhang; Kamel Khalili; Roberta A Gottlieb; J Manuel Perez; John S Yu
Journal:  Mol Cancer Res       Date:  2021-04-16       Impact factor: 5.852

9.  The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.

Authors:  Serena Pellegatta; Marica Eoli; Simona Frigerio; Carlo Antozzi; Maria Grazia Bruzzone; Gabriele Cantini; Sara Nava; Elena Anghileri; Lucia Cuppini; Valeria Cuccarini; Emilio Ciusani; Marta Dossena; Bianca Pollo; Renato Mantegazza; Eugenio A Parati; Gaetano Finocchiaro
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

10.  Elevated cell invasion in a tumor sphere culture of RSV-M mouse glioma cells.

Authors:  Motonobu Nonaka; Toshio Yawata; Mitsuhiro Takemura; Youichirou Higashi; Eiichi Nakai; Keiji Shimizu; Tetsuya Ueba
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-12-20       Impact factor: 1.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.